Don’t forget the toes: Managing patients with ANCA vasculitis

Active or not active, that is the question. In this week's episode we interview Alexandra Villa-Forte, MD, MPH, a staff physician in the Center for Vasculitis Care and Research at Cleveland Clinic and a leading vasculitis expert, on a pragmatic approach to recognizing disease activity in patients with ANCA vasculitis.

• · Intro 0:01
• · Welcome Alexandra Villa-Forte, MD, MPH 0:10
• · Dr. Brown sketches a potential patient that may be seen in practice 0:40
• · How are you monitoring patients’ kidneys? 1:28
• · How reliable are ‘no casts’ results in urinalysis tests? 4:15
• · What is happening in the glomeruli? 5:23
• · The importance of monitoring the urinalysis of patients with ANCA vasculitis 7:06
• · Symptoms to watch for when tapering off medications 7:43
• · Different scenarios with lung symptoms 9:35
• · Evaluating patients with GPA; looking at the nose, ear and sinuses 12:20
• · Neurologic symptoms in ANCA vasculitis 14:24
• · Laboratory monitoring 15:52
• · Should ANCA titers be a part of routine vasculitis monitoring? 17:05
• · What is your approach using PJP prophylaxis in ANCA-associated vasculitis? 18:05
• Thank you, Dr. Villa-Forte! 20:25

We’d love to hear from you! Send your comments/questions to Dr. Brown at [e-mail]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

Disclosures: Brown reports no relevant financial disclosures. Healio was unable to confirm relevant financial disclosures for Villa-Forte at the time of publication.